| Date Filed | Type | Description |
| 08/18/2023 |
4
| MOORE JOHN R (General Counsel) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $7.08, valued at
$1.4M
|
|
| 05/03/2023 |
4
| MOORE JOHN R (General Counsel) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Sold 1,897 shares
@ $8.9049, valued at
$16.9k
Exercised 5,208 restricted stock units
@ $0 |
|
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2022 |
4
| MOORE JOHN R (General Counsel) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Sold 2,379 shares
@ $10.8262, valued at
$25.8k
Sold 2,351 shares
@ $10.992, valued at
$25.8k
Exercised 4,730 options to buy
@ $1.93, valued at
$9.1k
|
|
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2022 |
4
| MOORE JOHN R (General Counsel) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Exercised 5,400 options to buy
@ $0.71, valued at
$3.8k
|
|
| 12/30/2021 |
4
| MOORE JOHN R (General Counsel) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Exercised 5,400 options to buy
@ $0.71, valued at
$3.8k
|
|
| 08/19/2021 |
4
| MOORE JOHN R (General Counsel) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 120,000 options to buy
@ $16.38, valued at
$2M
|
|
| 03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/06/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/14/2016 |
4
| MOORE JOHN R (Director) has filed a Form 4 on Nivalis Therapeutics, Inc. |
| 04/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/03/2013 |
4
| MOORE JOHN R (VP, General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 11,666 shares
@ $5.79, valued at
$67.5k
|
|
| 08/02/2013 |
4
| MOORE JOHN R (VP, General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 31,500 shares
@ $7.0043, valued at
$220.6k
Sold 43,884 shares
@ $7.0292, valued at
$308.5k
Exercised 12,500 options to buy
@ $2.74, valued at
$34.3k
Exercised 14,241 options to buy
@ $3.01, valued at
$42.9k
Exercised 13,884 options to buy
@ $3.01, valued at
$41.8k
Exercised 30,000 options to buy
@ $3.06, valued at
$91.8k
|
|
| 07/25/2013 |
4
| MOORE JOHN R (VP, General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 5,000 shares
@ $6.5, valued at
$32.5k
Exercised 5,000 options to buy
@ $2.74, valued at
$13.7k
Exercised 4,759 options to buy
@ $3.75, valued at
$17.8k
|
|
| 04/24/2013 |
4
| MOORE JOHN R (VP, General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 20,000 shares
@ $6.52, valued at
$130.4k
Exercised 20,000 options to buy
@ $2.74, valued at
$54.8k
|
|
| 10/09/2012 |
4
| MOORE JOHN R (VP, General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 26,190 shares
@ $5.6858, valued at
$148.9k
Sold 2,357 shares
@ $5.6858, valued at
$13.4k
|
|
| 10/05/2012 |
4
| MOORE JOHN R (VP, General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Granted 11,886 shares
@ $0 |
|
| 04/03/2012 |
4
| MOORE JOHN R (VP, General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Granted 75,000 options to buy
@ $3.4, valued at
$255k
|
|
| 10/04/2011 |
4
| MOORE JOHN R (VP, General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Granted 26,190 shares
@ $0
Granted 2,357 shares
@ $0 |
|
| 04/05/2011 |
4
| MOORE JOHN R (VP, General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Granted 60,000 options to buy
@ $3.06, valued at
$183.6k
Granted 1,250 options to buy
@ $3.06, valued at
$3.8k
|
|
| 04/05/2011 |
4
| MOORE JOHN R (VP, General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 356 shares
@ $3.3, valued at
$1.2k
|
|
| 01/12/2011 |
4
| MOORE JOHN R (VP, General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 593 shares
@ $3.3, valued at
$2k
Sold 2,366 shares
@ $3.3, valued at
$7.8k
|
|
| 01/06/2011 |
4
| MOORE JOHN R (VP, General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 24,039 shares
@ $3.25, valued at
$78.1k
|
|
|